Press Releases

Press Release

Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases

The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo Results indicate that vaccination with SCB-2019 can […]
Dr. Jerome Kim (left), Director General of the International Vaccine Institute and Dr. Kyungjin Peter Kim, CEO of ST Pharm, pose for a photo as they exchange a memorandum of understanding at a signing ceremony at IVI headquarters in Seoul on November 24, 2022.

IVI, ST Pharm exchange MOU on clinical development of COVID-19 vaccine

Agreement to strategic partnership and collaboration for clinical development of pan-coronavirus mRNA vaccines; promotion of Global Training Hub for Biomanufacturing (GTH-B) for LMICs November 24, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) and ST Pharm announced November 24 that they exchanged […]
Press Release

Biovac signs deal with IVI to develop and manufacture oral cholera vaccine for African and global markets

November 22, 2022, SEOUL, Republic of Korea – South African based Bio-pharmaceutical company, Biovac, has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV). […]
Prof. Jeong-Taek Woo, General Director of GVL (left) and Dr. Jerome Kim, Director General of IVI (right), sign an MOU to establish a cooperative partnership between GVL and IVI.

IVI partners with Global Vaccine Leading Technology Center to accelerate vaccine development for global health

November 22, 2022, SEOUL, Republic of Korea – The Global Vaccine Leading Technology Center (GVL) in the Republic of Korea and the International Vaccine Institute (IVI) signed a memorandum of understanding (MOU) on November 21 to cooperate in vaccine development for global health. The MOU […]
SK bioscience held a ceremony to make a philanthropic grant for R&D to the International Vaccine Institute at SK bioscience headquarters in Seongnam  on November 16. 
(from left) SK Discovery Vice Chairman Chang-won Chey, and SK bioscience President Jae-yong Ahn, Dr. B.G. Rhee, Chairman of the Korea Support Committee for IVI’s Board of Trustees, and IVI Director General Dr. Jerome Kim.

SK bioscience makes donation to IVI to support global R&D

SK bioscience, IVI convene consultative meeting to discuss cooperation for next pandemic Company announces KRW3 billion donation to IVI to support advancement of global vaccine R&D November 17, 2022, SEOUL, Republic of Korea – SK bioscience, a leading vaccine manufacturer based in the Republic of […]
Representative-images(1)

Lemonex, IVI exchange MOU on joint vaccine development

November 10, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) announced on November 10 it signed a memorandum of understanding (MOU) with Lemonex, a company specializing in RNA gene therapy development, and agreed to seek cooperation in research and development. IVI and Lemonex […]

GTH-B_GxP

IVI conducts 1st Introductory Course for Standard Practice (GxP Course) Oct. 31 – Nov. 18

Course to educate 230 trainees from 33 LMICs and 42 Koreans on GxP to bridge basic knowledge and hands-on training to produce skilled personnel in biomanufacturing   October 31, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) kicked off the ‘Introductory Course […]
H.E. Anutin Charnvirakul, Thailand’s Deputy Prime Minister and Minister of Public Health, raises the flag of Thailand at IVI HQ during the Thailand-IVI Ratification Ceremony.

IVI welcomes Thailand as a state party

H.E. Anutin Charnvirakul, Thailand’s Deputy Prime Minister and Minister of Public Health, made an official visit to IVI: “I strongly believe that a robust collaboration between Thailand and IVI will bring us many opportunities for vaccine research and development, and enable stronger immunization support globally." […]
During the 25th Anniversary Celebration, IVI honored 4 key figures in IVI's establishment with the IVI Founders Medal. From left to right: George Bickerstaff (Chairperson of IVI's BOT), Prof. Seung Il Shin (awardee), Prof. Barry Bloom (awardee),
Prof. Wan Kyoo Cho (awardee), 
Prof. Sang-Dai Park (awardee), Dr. Jerome Kim (Director General of IVI).

IVI gathers member countries for 2022 State Forum and celebrates its 25th anniversary with key partners

October 21, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, held its annual State Forum in Seoul yesterday, bringing together representatives from IVI’s […]
•	On October 20, 2022, the International Vaccine Institute (IVI) launched its Global Advisory Group of Experts (GAGE) chaired by Dr. Deborah Birx to advise IVI on matters of global health and diplomacy. Other founding GAGE members include Dr. Anders Nordström (Vice Chairperson), Dr. Agnès Buzyn, Dr. Carla Vizzotti, Dr. Kyung-wha Kang, Dr. Samba Sow, and Dr. Yasuhiro Suzuki.

IVI launches Global Advisory Group of Experts chaired by Dr. Deborah Birx

October 20, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, launched its Global Advisory Group of Experts today during its inaugural meeting held […]
Representative-images(1)

IVI signs memorandum of understanding with Hilleman Laboratories to advance vaccine R&D and manufacturing for safe, effective, and affordable vaccines in low-and middle-income countries

October 4, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) has signed a three-year Memorandum of Understanding (MOU) with Hilleman Laboratories to establish a collaborative relationship in the pursuit of joint research and development of vaccines to broaden the availability of safe, […]
Press Release

IVI and the London School of Hygiene & Tropical Medicine partner to accelerate vaccines for global health through joint training and research and development

October 3, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and the London School of Hygiene & Tropical Medicine (LSHTM) signed a Memorandum […]
220926-150308REV07900

IVI’s 21st International Vaccinology Course highlights breakthroughs in vaccine science and technology

September 27, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, kicked off its annual International Vaccinology Course on Monday. This year’s course will […]
Press Release

IVI’s Europe Regional Office begins operations in Stockholm

September 1, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, opened the IVI Europe Regional Office (IERO) in Stockholm today. IERO, housed temporarily […]

Dr. Jerome Kim, Director General of IVI (left), and H.E. Magnus Heunicke, Minister for Health of Denmark, meet at IVI headquarters during the Minister's official visit to the ROK.

Danish Minister for Health visits the International Vaccine Institute during official visit to Republic of Korea

Danish Government to contribute 4 million Danish kroner to IVI in 2022 IVI and the Embassy of Denmark in Korea co-organized a seminar on vaccine development and AMR August 30, 2022, SEOUL, Republic of Korea – The Danish Minister for Health, H.E. Magnus Heunicke, visited […]
138 trainees from 25 countries completed the 2022 Introductory Course for Biologics Development and Manufacturing, the first course of the Global Training Hub for Biomanufacturing initiative.

First ‘Introductory Course for Biologics Development and Manufacturing’ completes training of 106 participants from 24 countries, and 32 Koreans

Africa CDC’s PAVM provided travel scholarships to 50 trainees from 14 African countries IVI to conduct the ‘2022 Introductory Course for Standard Practice (GxP Course)’ in October to educate 300 trainees and bridge basic knowledge with hands-on training July 29, 2022, SEOUL, Republic of Korea […]
Dr. Jerome Kim, Director General of IVI, and Dr. Paul Burton, Chief Medical Officer of Moderna, exchange a memorandum of understanding for R&D collaboration at IVI headquarters in Seoul, Korea on July 20, 2022.

IVI and Moderna sign memorandum of understanding for vaccine research and development

July 20, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, signed […]
Global Bio-Intensive Training Courses

IVI kicks off first ‘Introductory Course for Biologics Development and Manufacturing’ to train 117 people from 25 LMICs on July 18

Funded by Korean MOHW, new course is conducted as part of 'Global Bio-Intensive Training Courses’ to promote Korea as Global Training Hub for Biomanufacturing 2-week program expected to help increase LMICs’ capability in local bio production to address vaccine inequity, enhance global pandemic preparedness July […]
His Excellency Juan Ignacio Morro, Ambassador of the Kingdom of Spain to the Republic of Korea, raises the Spanish flag at IVI headquarters today during the accession ceremony.

Spain joins IVI with flag-raising ceremony

June 20, 2022 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced that Spain joined IVI, an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.   His Excellency Juan Ignacio Morro, Ambassador of […]
Press Release

Typhoid: Multi- and single-dose formulations of Vi-DT vaccine shown to be safe and immunologically equivalent in new study

New evidence supports the use of alternative dosing formulations, expanding TCV delivery options in public health programs     June 14, 2022 – SEOUL, Republic of Korea – A new study jointly conducted by the International Vaccine Institute (IVI) and collaborators shows multidose and single-dose […]

EAPD-IVI-Vaccine-Symposium-Banner(0520)

International Vaccine Institute and Egyptian Agency of Partnership for Development co-host symposium on African vaccine manufacturing

June 7, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) and Egyptian Agency of Partnership for Development (EAPD) held the 2022 EAPD-IVI Online Vaccine Symposium today to support the advancement of vaccine manufacturing capacity in Africa.   The symposium highlighted challenges and […]
Her Excellency Yasmin D. Amri Sued, Ambassador of the Republic of Rwanda to the Republic of Korea, raises the flag of Rwanda at IVI headquarters during a ceremony celebrating the accession of Rwanda to IVI.

IVI welcomes Rwanda as a member state with flag-raising ceremony

June 3, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) is pleased to announce that the Republic of Rwanda joined IVI, an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health. Her Excellency […]
Left to right: Dr. Se Eun Park, H.E. Kang Seok-hee, H.E. Dereje Duguma, Mr. Seunghwan Yang, and Dr. Shallo Dhaba cut the ribbon to officially open the AHRI-IVI Collaborating Center in Addis Ababa, Ethiopia on May 23, 2022.

IVI and AHRI establish Collaborating Center for joint vaccine research, development, and capacity-building for global health

  May 23, 2022– SEOUL, Republic of Korea and ADDIS ABABA, Ethiopia – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines, and Armauer Hansen Research Institute (AHRI), established by the Government of […]

CAPTURA_Bangladesh_20220518

IVI and the Government of Bangladesh join forces to boost AMR response in South Asia

May 18, 2022, SEOUL, Republic of Korea – Today, the International Vaccine Institute (IVI) and the Ministry of Health, and Family Welfare (MOHFW) of Bangladesh shared key findings from the Capturing data on Antimicrobial resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) […]
Ethiopia OCV vaccination

IVI, LG Electronics, Korean donors, AHRI and EPHI join hands to vaccinate 100,000 people at risk of cholera in Ethiopia

2 ECCP projects to contribute to the government’s efforts towards control and prevention of cholera and diarrheal diseases May 13, 2022, SEOUL, Korea — The International Vaccine Institute (IVI), in collaboration with LG Electronics, the Ethiopian government led by Armaur Hansen Research Institute (AHRI), and the […]
Dr. Eun-kyung Jeong, Commissioner of the Korea Disease Control and Prevention Agency, and Dr. Jerome Kim, Director General of the International Vaccine Institute, exchange a memorandum of understanding on mutual cooperation at KDCA headquarters in Osang, Korea on May 13, 2022.

IVI, KDCA exchange MOU on ROK’s state funding, strengthened cooperation

Agree to expand collaboration in vaccine development & delivery, training Exchange additional letter of intent on cooperation in epidemiology training May 13, 2022, SEOUL, Korea — The International Vaccine Institute (IVI) and the Disease Control and Prevention Agency (KDCA), Republic of Korea, exchanged a memorandum of […]
SK bioscience -IVI

New typhoid conjugate vaccine licensed in Korea

‘SKYTyphoid’ TCV developed jointly by IVI and SK bioscience, licensed for export by Korean Ministry of Food and Drug Safety Vaccine demonstrates non-inferiority to comparator vaccine PQed by WHO; single dose provides long-term protection Vaccine will be available to infants under age 2; SK bioscience […]
ivy2022-05-31

IVI and SK bioscience confirm SK’s COVID-19 vaccine candidate meets coprimary objectives in a joint 6-country Phase III study

Recombinant protein-based ‘SKYCovione™’ adjuvanted with GSK’s pandemic adjuvant demonstrates superior neutralizing titers compared to a control vaccine and safety SK bioscience submits a biologics license application to KMFDS, and will submit license applications to international regulatory agencies Company set to supply 10 million doses of […]

A child receives oral cholera vaccine (OCV) during a vaccination campaign in Rupani, Nepal.

IVI, SmileGate, partners team up to vaccinate 28,000 people in Nepal

OCV vaccination campaign targets Rupani Rural Municipality to control ongoing outbreak of cholera and diarrheal diseases Project to assess feasibility of self-administration strategy for the 2nd dose of OCV May 4, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), in collaboration with SmileGate […]
IVI hosts the first annual IVI-SK bioscience Park MahnHoon Award Ceremony at its headquarters.

2022 IVI-SK bioscience Park MahnHoon Award Ceremony honors Dr. Tore Godal, Profs. Drew Weissman & Katalin Karikó

8th UN Secretary-General Ban Ki-moon congratulates awardees, lauds their contributions to global health and vaccine innovation April 25, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) hosted the 2022 Award Ceremony of the IVI-SK bioscience Park MahnHoon Award today, honoring Dr. […]
Representative-images(1)

International Vaccine Institute appoints two members to its Board of Trustees representing Ecuador and Rwanda

April 20, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with the mission to discover, develop and deliver safe, effective and affordable vaccines for global health, announced today that Dr. Ximena Garzón Villalba, Minister of Public Health of […]
Health and Welfare Minister Dr. Kwon Deok-cheol (center-right), and Director General Dr. Jerome Kim (center-left) and participants pose for a commemorative photo as they exchange the MOU during a signing ceremony at IVI headquarters in Seoul on April 1, 2022.

IVI, ROK’s MOHW expand partnership to promote vaccine development & delivery, bio manufacturing training for LMICs

April 1, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) and the Ministry of Health and Welfare (MOHW), Republic of Korea, have agreed to strengthen cooperation to promote the development and delivery of vaccines and bio manufacturing workforce training for low- and […]

Dr. Tore Godal, Profs. Drew Weissman & Katalin Karikó honored with first IVI – SK bioscience Park MahnHoon Award

Godal recognized for contributions to delivery of crucial vaccines for millions of children in low-income countries Weissman and Karikó honored for the development of pivotal mRNA technology for vaccines against COVID-19 Award ceremony to take place at IVI on April 25 March 24, 2022 – […]
IB__5736

IVI welcomes the United Arab Emirates as its 37th member state with flag-raising ceremony

  March 17, 2022 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the United Arab Emirates (UAE) joined IVI, becoming the international organization’s 37th member state. His Excellency Abdulla Saif Al Nuaimi, Ambassador of the UAE to the Republic of […]

Participants pose for a commemorative group photo during the 19th IVI International Vaccinology Course at IVI in Seoul, Korea in September 2019.

IVI named operator of ‘2022 Global Bio-Intensive Training Courses’ by Korean Ministry of Health and Welfare

Institute to run training program on vaccines and biologics development and manufacturing and GxP for 450 trainees from LMICs and Korea   February 16, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) has been designated by the Ministry of Health and Welfare […]

Press Release

New studies: Vi-DT vaccine is safe and immunogenic, with booster dosing potentially eliciting long-term immune responses

January 27, 2022 – SEOUL, Republic of Korea – A new study shows that late booster dosing with Vi polysaccharide conjugated with diphtheria toxoid (Vi-DT), one of the typhoid conjugate vaccines (TCVs), at 27.5 months post-first dose is safe and elicits robust immune responses in […]

Dr. Jerome Kim (right), Director General of IVI, and Dr. Manki Song (left), Deputy Director General of IVI (Credit: IVI)

IVI and NVI partner for collaborative vaccine R&D and capacity building

  IVI and the National Vaccine Institute (NVI) of Thailand signed a Definitive Agreement to strengthen their collaborative partnership   January 20, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) and the National Vaccine Institute (NVI) of Thailand signed a Definitive […]

quote-card(revised)

IVI and SK bioscience Complete Recruitment for Phase III Clinical Trial of SKBS’ COVID-19 Vaccine

Recruitment of global Phase III clinical trial of ‘GBP510’ completed, with vaccine expected to be authorized in the first half of 2022 A booster dose study is concurrently being planned to bring additional vaccine to the global COVID-19 vaccine market   January 19, 2022 SEOUL, […]

Press Release

IVI and Mozambique’s INS launch mix-and-match COVID-19 vaccine study

Study will assess the safety and immunogenicity of a heterologous regimen of two approved COVID-19 vaccines in adults Aims to mitigate vaccine shortages and support flexible immunization programs   December 20, 2021, SEOUL, Republic of Korea; MAPUTO, Mozambique; OSLO, Norway – The International Vaccine Institute […]

IVI Regional Office

IVI to establish a European regional office in Sweden

IVI and the Government Offices of Sweden signed a Memorandum of Understanding today to establish the office in Stockholm, creating a European hub for global health research and innovation   December 17, 2021, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international […]

1. Webinar_-Curbing-the-invisible-Pandemic

IVI, ADB SEADS, IPK, ICARS, and the Danish Embassy in Korea launch webinar on combatting antimicrobial resistance

    The webinar “Curbing the Invisible Pandemic: Effective Solutions to Collectively Combat Antimicrobial Resistance” was held on December 7, 2021   December 7, 2021 — The International Vaccine Institute (IVI), Asian Development Bank Southeast Asia Development Solutions (ADB SEADS), Institut Pasteur Korea (IPK), the […]

Dr. Sushant Sahastrabuddhe of IVI named ‘Honorary Citizen of Seoul’

Cited for contributions to development of vaccines, joining 8 foreign residents to receive Honorary Citizenship in 2021 Second Honorary Seoul Citizen from IVI   SEOUL, Korea — Dr. Sushant Sahastrabuddhe, Associate Director General at the International Vaccine Institute (IVI), has been awarded “Honorary Citizenship of […]

SK바이오사이언스 안재용 사장(왼쪽), 故박만훈 부회장의 아내 이미혜 여사(중간). 국제백신연구소 사무총장 제롬 김(오른쪽)이 기념촬영을 하고 있다. 사진=SK바이오사이언스 제공

IVI partners with SK bioscience to launch new prestigious award for vaccine industry

IVI, SK sign an agreement to launch the ‘Park MahnHoon Award’ to honor individuals and organizations that made contributions to the vaccine industry Award Ceremony will be held annually in April; IVI and SK ‘committed to establish the new award as a prestigious award for […]

LBS_7669-1

IVI Director General named Honorary Ambassador of Korean Tourism

To promote the safety and attractiveness of traveling Korea amidst gradual restart of global tourism     The Ministry of Culture, Sports and Tourism (Minister Hwang Hee) and the Korea Tourism Organization (KTO, President Ahn Young-bae) appointed Dr. Jerome H. Kim, Director General of the […]

25일 개최된 ‘개발협력의 날’ 기념식에서 제롬 김 사무총장이 김부겸 국무총리로부터 대통령 단체표창을 수여받고 기념촬영을 하고 있다. 사진=국제백신연구소

IVI receives Development Cooperation Award from Republic of Korea

  The International Vaccine Institute (IVI) has been honored with the Presidential Citation of the Republic of Korea’s Development Cooperation Award, in recognition of IVI’s contributions to global health and Korea’s official development assistance.   IVI has been cited as being an “International organization focused […]

Dr. Jerome Kim (left), Director General of IVI, moderates the Health Security session of the World Emerging Security Forum at a Seoul hotel on November 16, 2021.

IVI leaders address health security at ‘first World Emerging Security Forum’ in Seoul

  Dr. Jerome Kim, Director General and Dr. Song Manki, Deputy Director General of Science of the International Vaccine Institute (IVI) joined distinguished global leaders and experts as moderator and speaker at the first World Emerging Security Forum, which took place in Seoul on November […]

Press Release

IVI and JEDI partner for innovations in health and science

October 25, 2021 – SEOUL, Republic of Korea, PARIS, France, BRUSSELS, Belgium, BERLIN, Germany – The International Vaccine Institute (IVI) and the Joint European Disruptive Initiative (JEDI) signed a Memorandum of Understanding to establish a collaborative relationship. Both organizations are dedicated to advancing innovations in […]

IVI State Forum 2021

IVI’s 2021 State Forum highlights opportunities to bridge global vaccine gaps

Until Everyone Is Safe: Global Vaccine Needs and IVI’s Capabilities was livestreamed on October 7, 2021 at 16:00 Korea Standard Time, and a recording of the event is available here.         October 7, 2021, SEOUL, Republic of Korea — The International Vaccine […]

Press Release

The International Vaccine Institute, Texas Children’s Hospital, and Baylor College of Medicine partner for collaborative vaccine research

Sept. 28, 2021 – SEOUL, South Korea, and HOUSTON, Texas, USA – The International Vaccine Institute (IVI), the Texas Children’s Hospital Center for Vaccine Development, and Baylor College of Medicine’s National School of Tropical Medicine signed a Memorandum of Understanding to promote and further academic […]

Press Release

Enrollment begins for Sanofi and GSK’s Phase 3 efficacy trial of COVID-19 vaccine candidate in Nepal, led by IVI

International Vaccine Institute (IVI) will lead the clinical trial in Nepal to assess the safety, efficacy and immunogenicity of an adjuvanted recombinant-protein COVID-19 vaccine candidate Phase 3 international clinical trial includes volunteers from several countries, including sites in the US, Asia, Africa and Latin America […]

이미지 = 국제백신연구소

IVI’s 20th International Vaccinology Course brings virtual training to vaccine professionals and students across 155 countries

September 10, 2021, SEOUL, Korea — The International Vaccine Institute’s (IVI) 20th International Vaccinology Course (IVC) concluded today, bringing together 7,350 registered trainees and 27 faculty members for 5 days of online lectures on a range of topics related to the science of vaccines with […]

이미지 = 국제백신연구소

IVI 20th International Vaccinology Course kicks off September 6, 2021

Learn more and register for the free 5-day virtual course (6-10 September 2021) on a range of topics related to vaccinology here September 6, 2021 SEOUL, Korea — The International Vaccine Institute’s (IVI) 20th annual International Vaccinology Course (IVC), a 5-day free, online course begins […]
20210825_08

President Duque of Colombia visits the International Vaccine Institute

The President of Colombia delivers letter of intent for Colombia to join IVI IVI and Colombia’s Ministry of Health and Social Protection sign memorandum of understanding August 25, 2021 – SEOUL, Republic of Korea – The President of the Republic of Colombia, His Excellency Iván […]
GCCDP site_Costa Rica

IVI and BBIL launch global Chikungunya vaccine Phase II/III trial in Costa Rica

IVI is leading the Global Chikungunya vaccine Clinical Development Program (GCCDP) consortium in partnership with Bharat Biotech International Ltd. and with support from the Coalition for Epidemic Preparedness Innovations (CEPI) and Ind-CEPI.   August 24, 2021 – SEOUL, Republic of Korea – The International Vaccine […]

Sae Eun Kim

IVI appoints ballerina Sae Eun Park to IVI Goodwill Ambassador

August 18, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) named Sae Eun Park, an award-winning ballet dancer from Korea, an IVI Goodwill Ambassador during a virtual ceremony in Seoul today.   Ms. Park was named danseuse étoile, the highest-level dancer, […]

Press Release

IVI partners with SK bioscience to conduct late-stage global clinical trials of SK bioscience’s COVID-19 vaccine

IVI to conduct Phase 3 clinical trials of SK bioscience’s recombinant protein vaccine candidate (GBP510) in Europe and Southeast Asia   Additionally, IVI forms partnership with SK and KNIH to jointly conduct antibody testing for the global trials to accelerate development of “Wave 2” vaccines […]
IMG_4143

THECA consortium begins Vi-TT typhoid conjugate vaccine phase IV effectiveness study in Ghana

July 26, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) announced today the start of a cluster-randomized, controlled Phase IV trial to assess the effectiveness of Typbar® typhoid conjugate vaccine (TCV) in preventing typhoid infection in children in Asante Akim, Ghana […]

Press Release

CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa

July 20, 2021; Oslo, Norway and Seoul, Republic of Korea: The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa. CEPI will provide funding […]

Bangladesh-IVI Ratification Ceremony_Flag Raising_Abida Islam_01

IVI welcomes Bangladesh as state party with ratification ceremony

  July 15, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) hosted a ceremony at headquarters today honoring the People’s Republic of Bangladesh’s ratification of the IVI Establishment Agreement. Over 20 years of vaccine research and capacity-building initiatives with partners in Bangladesh […]

KNUST-IVI CC

IVI and KNUST establish collaborating center to conduct vaccine research and development for global health

July 5, 2021 – SEOUL, Republic of Korea and KUMASI, Ghana – The International Vaccine Institute (IVI) and the Kwame Nkrumah University of Science and Technology (KNUST) opened the KNUST-IVI Collaborating Center today with a ceremony at KNUST/Agogo Presbyterian Hospital.   The KNUST-IVI Collaborating Center […]
The ROK-Australia-ASEAN Vaccine Forum was moderated by Dr. Anh Wartel, Deputy Director General at IVI (left on monitor), and Dr. Jerome Kim, Director General of IVI, gave welcoming remarks. Credit: IVI

IVI organizes ROK-Australia-ASEAN Vaccine Forum to promote inclusive and sustainable recovery from the COVID-19 pandemic

The ROK-Australia-ASEAN Vaccine Forum took place in hybrid live/virtual format with transmission from Seoul on June 29, 2021   June 29, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) organized, and the Republic of Korea’s Ministry of Foreign Affairs (MOFA) and […]

Representative-images(1)

IVI to develop an adaptive Phase 1b/2a schistosomiasis vaccine clinical trial

May 31, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded a grant to IVI to develop an adaptive trial design protocol for a Phase 1b/2a clinical trial of a schistosomiasis vaccine.   […]

Press Release

International Vaccine Institute and FII Institute sign MOU to cooperate on scientific research and publication

The agreement is an effort to further scientific research in infectious diseases and make knowledge more accessible through advocacy and joint publications.   May 19, 2021 – SEOUL, South Korea, RIYADH, Saudi Arabia – The International Vaccine Institute (IVI) and the Future Investment Initiative Institute […]

IVI Director General Dr. Jerome Kim and IPK CEO Dr. Youngmee Jee hold the signed MOU following the ceremony at IVI headquarters.

International Vaccine Institute and Institut Pasteur Korea Sign MOU for Research and Development of Infectious Disease Therapeutics and Vaccines

April 1, 2021, GYEONGDO-DO and SEOUL, Korea – The International Vaccine Institute (IVI) and the Institut Pasteur Korea (IPK) signed a memorandum of understanding (MOU) for mutual collaboration in the research and development of therapeutics and vaccines for infectious diseases.   The MOU signing ceremony, […]

IVI x NHRC MOU signing

IVI signs Memorandum of Understanding with the Nepal Health Research Council

  March 12, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) and the Nepal Health Research Council (NHRC) signed a Memorandum of Understanding (MoU) today during a virtual ceremony, laying the foundation for the two organizations to build research and development capacity […]
Press Release

IVI welcomes Bangladesh’s accession to IVI

March 9, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) welcomes the Cabinet of Bangladesh’s decision to ratify the IVI Establishment Agreement on February 22, 2021, completing the full accession process to IVI and becoming its 19th State Party.     Bangladesh is a founding signatory to IVI’s […]

Representative-images(1)

George Bickerstaff re-elected Chairperson of the International Vaccine Institute’s Board of Trustees

February 22, 2021, SEOUL, Korea – The International Vaccine Institute (IVI) announced today that its Board of Trustees (BOT) re-elected Mr. George Bickerstaff as Chairperson of the BOT. His second three-year term will begin this May.   Mr. Bickerstaff has served on the IVI Board […]

Participants pose for a commemorative photo  at the MOU signing ceremony between GI-Cell and the International Vaccine Institute at IVI headquarters on January 25, 2021.

GI-Cell, IVI sign MOU to develop next-generation COVID-19 vaccine

To cooperate in clinical development of COVID-19 vaccine candidate GI-Cell aims to prioritize supplying to Korea and developing countries by developing a vaccine that accommodates mass supply, viral mutation response, safety, convenience of patients January 26, 2021, SEOUL, Korea – GI-Cell, an affiliate of GI-Innovation, […]
ivi_logo

Cellid, IVI exchange ‘COVID-19 Vaccine Research Service Contract’

IVI to analyze samples from Phase 1/2a trials of Cellid’s COVID-19 vaccine to evaluate immunogenicity   January 5, 2021, SEOUL, Korea –  Cellid and the International Vaccine Institute (IVI) have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19”.   […]

Typhoid-2

IVI-SK’s new typhoid conjugate vaccine meets primary endpoints in phase III study in Nepal

Primary analysis also confirms safety of Vi-DT   December 17, 2020 – SEOUL, South Korea – Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal. The primary […]

From left: IVI Deputy Director General of Science Dr. Manki Song, EuBiologics co-CEO Dr. Yeong Ok Baik, IVI Director General Dr. Jerome Kim, and EuBiologics co-CEO Dr. Seuk-keun Choi

EuBiologics partners up with IVI in COVID-19 vaccine development

December 3, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) and EuBiologics exchanged an MOU to cooperate in clinical development of the COVID-19 vaccine the company is currently developing. The signing ceremony at IVI headquarters on December 2 was attended by Dr. Jerome […]

How to take action on AMR during the COVID-19 pandemic, a webinar co-hosted by IVI, ICARS, and the Embassy of Denmark in Korea

Free webinar, Evidence to Action: Advancing the Antimicrobial Resistance Agenda during a Pandemic, will be held on Thursday, December 3, 2020 at 9:00 Central European Time (17:00 Korean Standard Time). Registration available at ivi.int/evidence-to-action/    December 1, 2020, SEOUL, Korea — The International Vaccine Institute […]

Director General Jerome Kim and Commanding Officer Kim

IVI celebrates GivingTuesday with local community heroes and launches new donation initiative

December 1, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) visited the Seoul Gwanak Police Station today to recognize the Foreign Affairs section for their ongoing support for IVI’s activities and to deliver protective face masks and medical supplies for staff and volunteers. […]

School children receive oral cholera vaccine in the Cuamba District of Mozambique during a vaccination campaign in 2018. Credit: IVI

IVI, ROK’s GDEF join forces to provide OCV vaccination to 540,000 people at risk of cholera in Nepal and Mozambique

GDEF’s US$8.05 million grant to support ECHO projects to prevent and control cholera and contribute to ‘Ending Cholera—A Global Roadmap to 2030’   The International Vaccine Institute (IVI) and the Republic of Korea’s Global Disease Eradication Fund (GDEF) have agreed to conduct joint projects to […]

His Excellency Luis Gallegos, Minister of Foreign Affairs of the Republic of Ecuador (left), and Dr. Jerome Kim, Director General of IVI (right) signed a memorandum of understanding at IVI headquarters on November 24, 2020 to explore areas of collaboration in global health research and development. Credit: The Embassy of Ecuador to Korea

IVI and the Ministry of Foreign Affairs and Human Mobility of Ecuador exchange MOU to pursue global health research & development

November 24, 2020, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) and the Ministry of Foreign Affairs and Human Mobility of Ecuador exchanged a memorandum of understanding (MOU) today at IVI headquarters in Seoul, Republic of Korea to explore areas of collaboration in […]

IVI Director General Dr. Jerome Kim (left), IVI’s Korea Support Committee Chairman Prof. Sang Chul Park (right), and LG Electronics Senior Vice President Dae Sik Yoon exchange a Memorandum of Understanding at IVI headquarters in Seoul on November 24.

LG Electronics, IVI join forces to conduct a ‘cholera vaccination and prevention project’ in Ethiopia

Project to provide vaccination for 40,000 residents in areas at risk of cholera and establish disease monitoring system with the Ethiopian Ministry of Health through the Armauer Hansen Research Institute (AHRI) To contribute to health authorities in policymaking for disease prevention by investigating waterborne diseases […]

IVI, Vaccine Innovative Technology ALliance Korea (VITAL-Korea) to partner up for innovative vaccine research and development

Aim to accelerate R&D and globalization of Korean vaccines to increase contributions to global health     The International Vaccine Institute (IVI) and the Vaccine Innovative Technology ALliance Korea (VITAL-Korea) agreed to join forces to promote vaccine research and development for global health.   IVI […]

Dong-kyo Yang, Director General of the Korea Disease Control and Prevention Agency’s Bureau of Healthcare Safety and Immunization, presents a plague of commendation to Dr. Kyung Min Lee of the International Vaccine Institute (IVI). (Photo=Korea Disease Control and Prevention Agency)

International Vaccine Institute honored with Minister of Health and Welfare Award for achievements in biosafety

October 28, 2020, SEOUL, Korea —  The International Vaccine Institute (IVI) received an award by the Minister of Health and Welfare of the Republic of Korea for achievements in biosafety management.   IVI was honored with the Minister of Health and Welfare Award for achievements in […]

Mark Cuban, American entrepreneur and owner of the NBA's Dallas Mavericks, stars in a global campaign to promote the use of face masks to reduce the spread of COVID-19.

The International Vaccine Institute Supports a Global Campaign to Reduce the Spread of Covid-19

The International Vaccine Institute (IVI) is partnering with the World Sanity Foundation (WSF) in a campaign to encourage the use of face masks in an effort to reduce the spread of COVID-19 cases until a safe and effective vaccine becomes widely available.   The first […]

IVI and global health partners encourage vaccine diplomacy

October 13, 2020, SEOUL, Korea — The International Vaccine Institute (IVI) hosted a virtual State Forum today to advocate for multilateral cooperation through vaccine diplomacy. During a coronavirus pandemic with the continuous threat of more neglected infectious diseases spreading around the world, the forum convened […]

Typhoid: Study confirms Vi-DT conjugate vaccine is safe and immunogenic in children 6-23 months of age

September 17, 2020 – SEOUL, South Korea – A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of age, a group with high […]

IVI to ready clinical trial sites for COVID-19 vaccine efficacy trials in 4 countries

September 9, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded close to 1.5 million USD to IVI to support clinical trial site preparedness in four African and Asian countries to potentially support future COVID-19 Phase III efficacy vaccine trials.     Following successful completion of early-stage clinical trials of COVID-19 vaccine candidates, it will be […]
Ambassador Eero Suominen hoists the flag of Finland at the International Vaccine Institute after the country becomes the international organization’s 36th member state following an Accession Ceremony.

IVI welcomes Finland as 36th member state with flag-raising ceremony

  August 10, 2020 – SEOUL, South Korea – The flag of Finland was raised at the International Vaccine Institute (IVI) Headquarters today during a ceremony welcoming the country’s accession to IVI. Finland joined the Seoul-based international organization dedicated to vaccines for global health in […]

First Lady of South Korea Kim Jung-sook at IVI

IVI welcomes the First Lady of South Korea to a solidarity event for global health and vaccine equity

IVI hosted the “Shared Future, Global Solidarity: Vaccines Save Lives” event at its headquarters on July 8, 2020, attended by the First Lady, Minister of Health, Vice Minister of Foreign Affairs, Director of National Institute of Health of Korea, and foreign ambassadors to South Korea […]

BT21: Protect You by LINE x IVI

LINE and International Vaccine Institute Release BT21 Donation Stickers to Promote Global Vaccination and Vaccine Development

LINE FRIENDS’ BT21 characters featured in IVI sticker set to raise funds for child immunization initiatives and COVID-19 vaccine development   SEONGNAM, South Korea – June 30, 2020 – LINE Corporation today released a set of animated stickers together with the International Vaccine Institute (IVI) […]

IVI welcomes H.E. Einar H. Jensen, Ambassador of Denmark to South Korea, to discuss COVID-19 and AMR research

  June 16, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) welcomed His Excellency Einar H. Jensen, Ambassador of Denmark to South Korea, to IVI’s headquarters today to discuss developments in COVID-19 research as well as the institute’s ongoing studies on antimicrobial resistance […]

IVI partners with Seoul National University Hospital to start Phase 1/2 clinical trial of INOVIO’s COVID-19 DNA (INO-4800) vaccine in South Korea

First COVID-19 vaccine clinical study approved in South Korea funded by CEPI through INOVIO, and supported by KCDC/KNIH 2-stage trial to test INOVIO’s COVID-19 vaccine (INO-4800) using well-established DNA platform technology in adults     June 4, 2020, SEOUL, Korea and PLYMOUTH MEETING, PA, USA […]

CEPI awards up to US$14.1million to consortium of IVI and Bharat Biotech to advance development of Chikungunya vaccine in collaboration with Ind-CEPI

  June 3 2020, Oslo, Norway; Seoul, South Korea; Telangana, India—CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, has announced a new partnering agreement with a consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to advance the development of […]

IVI standardizes on Veeva Vault QualityDocs to Improve Operational Efficiency

SEOUL, KOREA — March 10, 2020 — Veeva Systems (NYSE:VEEV) today announced that the International Vaccine Institute (IVI), a not-for-profit International Organization established in 1997 as an initiative by the United Nations Development Programme (UNDP), has implemented Veeva Vault QualityDocs to improve control and real […]

IVI presents COVID-19 vaccine and epidemiology research to H.E. Philippe Lefort, Ambassador of France to Korea

May 22, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) invited French Ambassador to Korea, Philippe Lefort, to IVI’s headquarters in Seoul, Korea today to share ongoing research and development on COVID-19.   His Excellency Philippe Lefort, French Ambassador to Korea (left), and […]

IVI to strengthen COVID-19 surveillance in sub-Saharan Africa with support from Sweden

IVI will leverage its network of infectious disease surveillance sites to conduct epidemiological studies of COVID-19 in Madagascar and Burkina Faso Sida’s contribution will significantly build in-country capacity to proactively respond to the pandemic     May 21, 2020 – SEOUL, South Korea – The […]

INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference

INO-4700 (GLS-5300) DNA vaccine demonstrates 100% binding and 92% neutralizing antibody responses against MERS-CoV INO-4800 DNA vaccine for COVID-19 currently in Phase 1 trial utilizes identical strategy targeting Spike protein and CELLECTRA intradermal delivery   PLYMOUTH MEETING, Pa. and SEOUL, KOREA – April 28, 2020 […]

line_icon_200_v3

LINE and International Vaccine Institute Team Up to Promote the Importance of Vaccination

LINE to offer an Official Account to IVI to promote the importance of vaccines and vaccination, as well as feature educational contents starring IVI Goodwill Ambassador Henry Lau LINE FRIENDS’ BT21 character IVI sticker set to be launched in the first half of the year […]

IVI, INOVIO, and KNIH to partner with CEPI in a Phase I/II clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea

  The Coalition for Epidemic Preparedness Innovations (CEPI) grants funding $6.9 million to INOVIO and IVI to conduct clinical testing in Korea for INOVIO’s COVID-19 vaccine candidate based on their well-established DNA platform technology Korea National Institute of Health (KNIH) to support IVI’s testing efforts […]

Processed with VSCO with q1 preset

International Vaccine Institute and Technical University of Denmark to strengthen external quality assurance in the face of rising antimicrobial resistance in Asia

The Asia Pacific region is vulnerable to the emergence and spread of AMR but there is little high-quality data available on the extent of its impact Quality-assured data is essential for building tailored strategies for preventing the spread of drug-resistant infections IVI is part of […]

IVI and Sweden renew partnership to accelerate vaccines for global public health

    January 13, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI), a Seoul, Korea-based international organization, announced today that the Swedish International Development Cooperation Agency (Sida) will continue to support IVI’s mission to accelerate vaccine research and development for global health […]

InternationalStandards_groupphoto

IVI to lead critical standard reagents availability for oral cholera vaccine manufacturing to ensure their uniform efficacy and help meet global demand

  January 9, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI) received a $1.4 million grant from the Bill & Melinda Gates Foundation to ensure critical standards and reagents are available to low-cost oral cholera vaccine (OCV) manufacturers in the global health […]

IVI appoints three new members to its Board of Trustees

December 18, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI), a Seoul, Korea-based international organization dedicated to accelerating vaccines for global health, announced today that Professor Gordon Dougan, Dr. Melanie Saville, and Dr. Jean-Marie Okwo-Bele will join its Board of Trustees (BOT) […]

IVI to Accelerate Efforts in iNTS Vaccine Development

An award from the Wellcome Trust’s Affordable Innovations for Global Health Flagship will support IVI’s development and selection of potential vaccine candidates There is currently no vaccine available to protect against invasive non-typhoidal salmonella (iNTS)   November 13, 2019 – SEOUL, South Korea – The […]

IVI acquires GCLP certification from Korean Ministry of Food and Drug Safety

Institute expected to increase contributions to vaccine development activities worldwide   November 1, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI), an international organization for vaccine development and delivery headquartered in Seoul, has been granted Good Clinical Laboratory Practice (GCLP) certification by […]

5b87609717aec7007873

IVI Awarded $4.5 Million Grant to Increase Accessibility of Oral Cholera Vaccine

October 28, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI) has received a $4.5 million grant from the Bill & Melinda Gates Foundation to simplify the current oral cholera vaccine (OCV) and further increase its accessibility. To date, the Gates Foundation has […]

IVIStateForum2019_Group

IVI Discusses Expanding Support for Global Collaboration on Vaccine R&D and Delivery with Top Foreign Diplomats in Seoul

IVI State Forum 2019 was attended by 8th UN Secretary-General Ban Ki-moon, as well as 30 distinguished guests, including 17 ambassadors and top diplomats in Seoul, and senior Korean government officials.   The IVI State Forum 2019 was attended by ambassadors and senior diplomats from […]

IVI-led Consortium Awarded Fleming Fund Regional Grant to Improve Data Sharing in Fight against Antimicrobial Resistance

September 24, 2019, SEOUL, Korea – The Chief Medical Officer for England, Dame Sally Davies, announced today during the 74th UN General Assembly that a consortium led by the International Vaccine Institute (IVI) has been awarded a £2.7m Fleming Fund Regional Grant to improve data […]

Vaccinology-groupphoto

IVI to help developing countries tackle the spread of infectious diseases by building capacity through vaccinology training in Seoul

19th IVI International Vaccinology Course brings together 175 trainees and faculty members from 49 countries The annual course has trained over 1,544 healthcare professionals in vaccine development, evaluation, production and policy to help increase developing nations’ capacity in vaccine research and immunization.     September […]

photo seta

IVI acquires supplemental funding for Severe Typhoid in Africa Program (SETA Plus)

  August 28, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI) has received additional funds of $4.33 million from the Bill & Melinda Gates Foundation to expand Severe Typhoid in Africa (SETA) Program activities in close alignment with the “Effect of a […]

download

IVI Director General Dr. Jerome Kim to join the Human Vaccines Project’s Efforts as One of Four Distinguished Global Leaders to Decode the Human Immune System

August 16, 2019 – SEOUL, South Korea – Dr. Jerome Kim, Director General of the International Vaccine Institute (IVI), joins the Human Vaccines Project as one of four distinguished global leaders to help push forward its effort to solve one the greatest public health challenges […]

Prof. Park Sang-chul, President of the Korea Support Committee for IVI, Prof. Sung Young-chul and IVI Director General Dr. Jerome Kim

Prof. Young Chul Sung, biotech leader, personally donates US$8.4 million to IVI

Fund to support IVI’s projects to vaccinate children in developing countries throughout Asia-Pacific and Africa, to develop vaccines against emerging viruses   Prof. Park Sang-chul, President of the Korea Support Committee for IVI, Prof. Sung Young-chul with his donation pledge and IVI Director General Dr. […]

shutterstock_668814304

New push to develop world’s first vaccine against the deadly Strep A bacteria killing hundreds of thousand

Streptococcus pyogenes bacteria, which causes scarlet fever and other infections   30 May 2019, SEOUL, South Korea – The International Vaccine Institute (IVI) and Australia’s Murdoch Children’s Research Institute (MCRI) will coordinate a global push to free the world of Group A Streptococcus (Strep A), […]

IVI-led CAPTURA consortium wins Fleming Fund award for work on antimicrobial resistance (AMR) data across Asia

SEOUL, South Korea — An international consortium, led by the International Vaccine Institute (IVI), has received funding from the UK’s Fleming Fund Regional Grants to conduct the Capturing Data on Antimicrobial Resistance (AMR) Patterns and Trends in Use in Regions of Asia (CAPTURA) project. The […]

IVI receives $15.7 million grant to conduct phase III trials of new Vi-DT typhoid conjugate vaccine manufactured by SK bioscience of Korea

– Grant from the Bill & Melinda Gates Foundation will support additional supply of novel TCV at affordable cost for public sector markets   SEOUL, Korea –The International Vaccine Institute (IVI) announces receipt of a $15.7 million-dollar grant from the Bill & Melinda Gates Foundation […]

7 Key participants

‘IVI Forum for Enhancement of Cooperation’ hosted jointly by the Korean Parliamentary Forum for Global Health, and KCDC under MOHW

– Event organized by IVI to discuss ways of cooperation to help increase Korea’s vaccine self-sufficiency, and accelerate globalization of the Korean vaccine industry Key participants pose for a commemorative photo at the ‘IVI Forum for Enhancement of Cooperation’ at the National Assembly of the […]

Vaccine study confirms sensitivity of cholera test

Recently, the sensitivity of fecal microbiological cultures for detecting cholera has come under question. Researchers reporting in PLOS Neglected Tropical Diseases investigated this claim using a ‘vaccine probe’ analysis of a completed cholera vaccine cluster randomized trial to support the sensitivity of conventional microbiological culture […]

ivi-0314-1

Korean Pediatric Association, IVI, KSC exchange MOU

KPA, as group of experts in pediatric infectious diseases, to collaborate in academic research and projects on infectious disease prevention To support vaccination of children in developing countries through the ‘One for Three’ campaign, in partnership with IVI     The International Vaccine Institute (IVI), […]

Children-3

IVI receives $3.2 million grant to support TCV effectiveness studies in West Africa

  SEOUL, Korea — The International Vaccine Institute (IVI) has been awarded a $3,238,974 grant from the Bill & Melinda Gates Foundation to provide technical assistance support for studies to measure the effectiveness of typhoid conjugate vaccine (TCV) in West Africa. This grant comes after […]

cepi

CEPI partners with IVI to accelerate development of vaccines against emerging global health threats

– Bilateral ‘Master Implementing Partner Services Agreement’ expected to enable IVI to provide technical capabilities to CEPI   Oslo, Norway; Seoul, Republic of Korea 11 February 2019—The Coalition for Epidemic Preparedness Innovations (CEPI) and the Republic of Korea-based International Vaccine Institute (IVI), an international organisation […]

henry

Henry Lau joins IVI as Goodwill Ambassador

– Singer-songwriter, Henry to team up with the International Vaccine Institute (IVI), founded by the United Nations Development Programme to develop and deliver new vaccines for global health – IVI Director General Dr. Jerome Kim: “IVI is privileged to have Henry on board, and grateful […]

Ghana_community_SeEunPark

Nature Communications study addresses MDR typhoid

New study in Nature Communications reveals high burden of multi-drug resistant (MDR) typhoid fever in sub-Saharan Africa associated with two predominant genotypes – IVI epidemiologist Se Eun Park and collaborating scientists report data from Typhoid Fever Surveillance in Africa (TSAP) program and other sources   […]

THSTI

THSTI, IVI held joint symposium on Nov. 22

First cooperative program between International Vaccine Institute and Translational Health Science and Technology Institute expected to help accelerate cooperation between India and IVI IVI and the Translational Health Science and Technology Institute (THSTI) of India held a joint symposium at IVI headquarters on November 22. […]

‘The Euvichol story’ published in Vaccine

“The Euvichol Story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships” spearheaded by the International Vaccine Institute (IVI), has been published in Vaccine by Elsevier. The Euvichol Story published on October 9, 2018 in the […]

IVI accelerates development of MERS vaccine

– Institute jointly conducts phase 1/2a clinical trial of GeneOne Life Science’s GLS-5300 DNA MERS vaccine – IVI in search of additional promising candidate vaccines among developers worldwide, with support from Samsung Life Public Welfare Foundation   The International Vaccine Institute (IVI) said on September […]

5b8f31ef6b8e69141418

IVI’s 18th Vaccinology Course gathers 120 international participants from 19 countries in Seoul September 3-7

Annual Course to update on the recent development in vaccinology, including basics of immunology, epidemiology, vaccine design and development Featured experts include: Stanley Plotkin (University of Pennsylvania), Dr. Barney Graham (US NIH), Dr. Randy Schoepp (USAMRID), Dr. Andy Pollard (University of Oxford), and Dr. Eric […]

5b87609717aec7007873

KOICA, IVI team up with Mozambican MoH and INS, partners to vaccinate 190,000 people against cholera

– Joint initiative aims to prevent and control cholera, and secure sustainable cholera and diarrheal disease surveillance  – WASH campaign to promote access to clean water and behavioral change for appropriate sanitation and hygiene practice – “KOICA is joining the program to contribute to ‘Ending […]

IVI acquires $5 million grant to support process development, scale up of typhoid conjugate vaccine with SK Bioscience

– Grant from the Bill & Melinda Gates Foundation to allow SK Bioscience Co. Ltd, IVI to accelerate late-stage development of new vaccine necessary to achieve WHO prequalification The International Vaccine Institute (IVI), an international nonprofit organization devoted to providing vaccines critical to global public […]

Clover’s Vaccine Candidate Reduced Household Transmission of SARS-CoV-2 in Study Published in Clinical Infectious Diseases

The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo Results indicate that vaccination with SCB-2019 can […]

IVI, ST Pharm exchange MOU on clinical development of COVID-19 vaccine

Agreement to strategic partnership and collaboration for clinical development of pan-coronavirus mRNA vaccines; promotion of Global Training Hub for Biomanufacturing (GTH-B) for LMICs November 24, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) and ST Pharm announced November 24 that they exchanged […]

Biovac signs deal with IVI to develop and manufacture oral cholera vaccine for African and global markets

November 22, 2022, SEOUL, Republic of Korea – South African based Bio-pharmaceutical company, Biovac, has concluded a ground-breaking licensing and technology transfer agreement with the International Vaccine Institute (IVI), a non-profit international organisation headquartered in South Korea, for the manufacture of an oral cholera vaccine (OCV). […]

IVI partners with Global Vaccine Leading Technology Center to accelerate vaccine development for global health

November 22, 2022, SEOUL, Republic of Korea – The Global Vaccine Leading Technology Center (GVL) in the Republic of Korea and the International Vaccine Institute (IVI) signed a memorandum of understanding (MOU) on November 21 to cooperate in vaccine development for global health. The MOU […]

SK bioscience makes donation to IVI to support global R&D

SK bioscience, IVI convene consultative meeting to discuss cooperation for next pandemic Company announces KRW3 billion donation to IVI to support advancement of global vaccine R&D November 17, 2022, SEOUL, Republic of Korea – SK bioscience, a leading vaccine manufacturer based in the Republic of […]

Lemonex, IVI exchange MOU on joint vaccine development

November 10, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) announced on November 10 it signed a memorandum of understanding (MOU) with Lemonex, a company specializing in RNA gene therapy development, and agreed to seek cooperation in research and development. IVI and Lemonex […]

IVI conducts 1st Introductory Course for Standard Practice (GxP Course) Oct. 31 – Nov. 18

Course to educate 230 trainees from 33 LMICs and 42 Koreans on GxP to bridge basic knowledge and hands-on training to produce skilled personnel in biomanufacturing   October 31, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) kicked off the ‘Introductory Course […]

IVI welcomes Thailand as a state party

H.E. Anutin Charnvirakul, Thailand’s Deputy Prime Minister and Minister of Public Health, made an official visit to IVI: “I strongly believe that a robust collaboration between Thailand and IVI will bring us many opportunities for vaccine research and development, and enable stronger immunization support globally." […]

IVI gathers member countries for 2022 State Forum and celebrates its 25th anniversary with key partners

October 21, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, held its annual State Forum in Seoul yesterday, bringing together representatives from IVI’s […]

IVI launches Global Advisory Group of Experts chaired by Dr. Deborah Birx

October 20, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, launched its Global Advisory Group of Experts today during its inaugural meeting held […]

IVI signs memorandum of understanding with Hilleman Laboratories to advance vaccine R&D and manufacturing for safe, effective, and affordable vaccines in low-and middle-income countries

October 4, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) has signed a three-year Memorandum of Understanding (MOU) with Hilleman Laboratories to establish a collaborative relationship in the pursuit of joint research and development of vaccines to broaden the availability of safe, […]

IVI and the London School of Hygiene & Tropical Medicine partner to accelerate vaccines for global health through joint training and research and development

October 3, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and the London School of Hygiene & Tropical Medicine (LSHTM) signed a Memorandum […]

IVI’s 21st International Vaccinology Course highlights breakthroughs in vaccine science and technology

September 27, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, kicked off its annual International Vaccinology Course on Monday. This year’s course will […]

IVI’s Europe Regional Office begins operations in Stockholm

September 1, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, opened the IVI Europe Regional Office (IERO) in Stockholm today. IERO, housed temporarily […]

Danish Minister for Health visits the International Vaccine Institute during official visit to Republic of Korea

Danish Government to contribute 4 million Danish kroner to IVI in 2022 IVI and the Embassy of Denmark in Korea co-organized a seminar on vaccine development and AMR August 30, 2022, SEOUL, Republic of Korea – The Danish Minister for Health, H.E. Magnus Heunicke, visited […]

First ‘Introductory Course for Biologics Development and Manufacturing’ completes training of 106 participants from 24 countries, and 32 Koreans

Africa CDC’s PAVM provided travel scholarships to 50 trainees from 14 African countries IVI to conduct the ‘2022 Introductory Course for Standard Practice (GxP Course)’ in October to educate 300 trainees and bridge basic knowledge with hands-on training July 29, 2022, SEOUL, Republic of Korea […]

IVI and Moderna sign memorandum of understanding for vaccine research and development

July 20, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, signed […]

IVI kicks off first ‘Introductory Course for Biologics Development and Manufacturing’ to train 117 people from 25 LMICs on July 18

Funded by Korean MOHW, new course is conducted as part of 'Global Bio-Intensive Training Courses’ to promote Korea as Global Training Hub for Biomanufacturing 2-week program expected to help increase LMICs’ capability in local bio production to address vaccine inequity, enhance global pandemic preparedness July […]

Spain joins IVI with flag-raising ceremony

June 20, 2022 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced that Spain joined IVI, an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.   His Excellency Juan Ignacio Morro, Ambassador of […]

Typhoid: Multi- and single-dose formulations of Vi-DT vaccine shown to be safe and immunologically equivalent in new study

New evidence supports the use of alternative dosing formulations, expanding TCV delivery options in public health programs     June 14, 2022 – SEOUL, Republic of Korea – A new study jointly conducted by the International Vaccine Institute (IVI) and collaborators shows multidose and single-dose […]

International Vaccine Institute and Egyptian Agency of Partnership for Development co-host symposium on African vaccine manufacturing

June 7, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) and Egyptian Agency of Partnership for Development (EAPD) held the 2022 EAPD-IVI Online Vaccine Symposium today to support the advancement of vaccine manufacturing capacity in Africa.   The symposium highlighted challenges and […]

IVI welcomes Rwanda as a member state with flag-raising ceremony

June 3, 2022, SEOUL, Republic of Korea – The International Vaccine Institute (IVI) is pleased to announce that the Republic of Rwanda joined IVI, an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health. Her Excellency […]

IVI and AHRI establish Collaborating Center for joint vaccine research, development, and capacity-building for global health

  May 23, 2022– SEOUL, Republic of Korea and ADDIS ABABA, Ethiopia – The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines, and Armauer Hansen Research Institute (AHRI), established by the Government of […]

IVI and the Government of Bangladesh join forces to boost AMR response in South Asia

May 18, 2022, SEOUL, Republic of Korea – Today, the International Vaccine Institute (IVI) and the Ministry of Health, and Family Welfare (MOHFW) of Bangladesh shared key findings from the Capturing data on Antimicrobial resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) […]

IVI, LG Electronics, Korean donors, AHRI and EPHI join hands to vaccinate 100,000 people at risk of cholera in Ethiopia

2 ECCP projects to contribute to the government’s efforts towards control and prevention of cholera and diarrheal diseases May 13, 2022, SEOUL, Korea — The International Vaccine Institute (IVI), in collaboration with LG Electronics, the Ethiopian government led by Armaur Hansen Research Institute (AHRI), and the […]

IVI, KDCA exchange MOU on ROK’s state funding, strengthened cooperation

Agree to expand collaboration in vaccine development & delivery, training Exchange additional letter of intent on cooperation in epidemiology training May 13, 2022, SEOUL, Korea — The International Vaccine Institute (IVI) and the Disease Control and Prevention Agency (KDCA), Republic of Korea, exchanged a memorandum of […]

New typhoid conjugate vaccine licensed in Korea

‘SKYTyphoid’ TCV developed jointly by IVI and SK bioscience, licensed for export by Korean Ministry of Food and Drug Safety Vaccine demonstrates non-inferiority to comparator vaccine PQed by WHO; single dose provides long-term protection Vaccine will be available to infants under age 2; SK bioscience […]

IVI and SK bioscience confirm SK’s COVID-19 vaccine candidate meets coprimary objectives in a joint 6-country Phase III study

Recombinant protein-based ‘SKYCovione™’ adjuvanted with GSK’s pandemic adjuvant demonstrates superior neutralizing titers compared to a control vaccine and safety SK bioscience submits a biologics license application to KMFDS, and will submit license applications to international regulatory agencies Company set to supply 10 million doses of […]

IVI, SmileGate, partners team up to vaccinate 28,000 people in Nepal

OCV vaccination campaign targets Rupani Rural Municipality to control ongoing outbreak of cholera and diarrheal diseases Project to assess feasibility of self-administration strategy for the 2nd dose of OCV May 4, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI), in collaboration with SmileGate […]

2022 IVI-SK bioscience Park MahnHoon Award Ceremony honors Dr. Tore Godal, Profs. Drew Weissman & Katalin Karikó

8th UN Secretary-General Ban Ki-moon congratulates awardees, lauds their contributions to global health and vaccine innovation April 25, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) hosted the 2022 Award Ceremony of the IVI-SK bioscience Park MahnHoon Award today, honoring Dr. […]

International Vaccine Institute appoints two members to its Board of Trustees representing Ecuador and Rwanda

April 20, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international organization with the mission to discover, develop and deliver safe, effective and affordable vaccines for global health, announced today that Dr. Ximena Garzón Villalba, Minister of Public Health of […]

IVI, ROK’s MOHW expand partnership to promote vaccine development & delivery, bio manufacturing training for LMICs

April 1, 2022, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) and the Ministry of Health and Welfare (MOHW), Republic of Korea, have agreed to strengthen cooperation to promote the development and delivery of vaccines and bio manufacturing workforce training for low- and […]

Dr. Tore Godal, Profs. Drew Weissman & Katalin Karikó honored with first IVI – SK bioscience Park MahnHoon Award

Godal recognized for contributions to delivery of crucial vaccines for millions of children in low-income countries Weissman and Karikó honored for the development of pivotal mRNA technology for vaccines against COVID-19 Award ceremony to take place at IVI on April 25 March 24, 2022 – […]

IVI welcomes the United Arab Emirates as its 37th member state with flag-raising ceremony

  March 17, 2022 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the United Arab Emirates (UAE) joined IVI, becoming the international organization’s 37th member state. His Excellency Abdulla Saif Al Nuaimi, Ambassador of the UAE to the Republic of […]

IVI named operator of ‘2022 Global Bio-Intensive Training Courses’ by Korean Ministry of Health and Welfare

Institute to run training program on vaccines and biologics development and manufacturing and GxP for 450 trainees from LMICs and Korea   February 16, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) has been designated by the Ministry of Health and Welfare […]

New studies: Vi-DT vaccine is safe and immunogenic, with booster dosing potentially eliciting long-term immune responses

January 27, 2022 – SEOUL, Republic of Korea – A new study shows that late booster dosing with Vi polysaccharide conjugated with diphtheria toxoid (Vi-DT), one of the typhoid conjugate vaccines (TCVs), at 27.5 months post-first dose is safe and elicits robust immune responses in […]

IVI and NVI partner for collaborative vaccine R&D and capacity building

  IVI and the National Vaccine Institute (NVI) of Thailand signed a Definitive Agreement to strengthen their collaborative partnership   January 20, 2022 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) and the National Vaccine Institute (NVI) of Thailand signed a Definitive […]

IVI and SK bioscience Complete Recruitment for Phase III Clinical Trial of SKBS’ COVID-19 Vaccine

Recruitment of global Phase III clinical trial of ‘GBP510’ completed, with vaccine expected to be authorized in the first half of 2022 A booster dose study is concurrently being planned to bring additional vaccine to the global COVID-19 vaccine market   January 19, 2022 SEOUL, […]

IVI and Mozambique’s INS launch mix-and-match COVID-19 vaccine study

Study will assess the safety and immunogenicity of a heterologous regimen of two approved COVID-19 vaccines in adults Aims to mitigate vaccine shortages and support flexible immunization programs   December 20, 2021, SEOUL, Republic of Korea; MAPUTO, Mozambique; OSLO, Norway – The International Vaccine Institute […]

IVI to establish a European regional office in Sweden

IVI and the Government Offices of Sweden signed a Memorandum of Understanding today to establish the office in Stockholm, creating a European hub for global health research and innovation   December 17, 2021, SEOUL, Republic of Korea – The International Vaccine Institute (IVI), an international […]

IVI, ADB SEADS, IPK, ICARS, and the Danish Embassy in Korea launch webinar on combatting antimicrobial resistance

    The webinar “Curbing the Invisible Pandemic: Effective Solutions to Collectively Combat Antimicrobial Resistance” was held on December 7, 2021   December 7, 2021 — The International Vaccine Institute (IVI), Asian Development Bank Southeast Asia Development Solutions (ADB SEADS), Institut Pasteur Korea (IPK), the […]

Dr. Sushant Sahastrabuddhe of IVI named ‘Honorary Citizen of Seoul’

Cited for contributions to development of vaccines, joining 8 foreign residents to receive Honorary Citizenship in 2021 Second Honorary Seoul Citizen from IVI   SEOUL, Korea — Dr. Sushant Sahastrabuddhe, Associate Director General at the International Vaccine Institute (IVI), has been awarded “Honorary Citizenship of […]

IVI partners with SK bioscience to launch new prestigious award for vaccine industry

IVI, SK sign an agreement to launch the ‘Park MahnHoon Award’ to honor individuals and organizations that made contributions to the vaccine industry Award Ceremony will be held annually in April; IVI and SK ‘committed to establish the new award as a prestigious award for […]

IVI Director General named Honorary Ambassador of Korean Tourism

To promote the safety and attractiveness of traveling Korea amidst gradual restart of global tourism     The Ministry of Culture, Sports and Tourism (Minister Hwang Hee) and the Korea Tourism Organization (KTO, President Ahn Young-bae) appointed Dr. Jerome H. Kim, Director General of the […]

IVI receives Development Cooperation Award from Republic of Korea

  The International Vaccine Institute (IVI) has been honored with the Presidential Citation of the Republic of Korea’s Development Cooperation Award, in recognition of IVI’s contributions to global health and Korea’s official development assistance.   IVI has been cited as being an “International organization focused […]

IVI leaders address health security at ‘first World Emerging Security Forum’ in Seoul

  Dr. Jerome Kim, Director General and Dr. Song Manki, Deputy Director General of Science of the International Vaccine Institute (IVI) joined distinguished global leaders and experts as moderator and speaker at the first World Emerging Security Forum, which took place in Seoul on November […]

IVI and JEDI partner for innovations in health and science

October 25, 2021 – SEOUL, Republic of Korea, PARIS, France, BRUSSELS, Belgium, BERLIN, Germany – The International Vaccine Institute (IVI) and the Joint European Disruptive Initiative (JEDI) signed a Memorandum of Understanding to establish a collaborative relationship. Both organizations are dedicated to advancing innovations in […]

IVI’s 2021 State Forum highlights opportunities to bridge global vaccine gaps

Until Everyone Is Safe: Global Vaccine Needs and IVI’s Capabilities was livestreamed on October 7, 2021 at 16:00 Korea Standard Time, and a recording of the event is available here.         October 7, 2021, SEOUL, Republic of Korea — The International Vaccine […]

The International Vaccine Institute, Texas Children’s Hospital, and Baylor College of Medicine partner for collaborative vaccine research

Sept. 28, 2021 – SEOUL, South Korea, and HOUSTON, Texas, USA – The International Vaccine Institute (IVI), the Texas Children’s Hospital Center for Vaccine Development, and Baylor College of Medicine’s National School of Tropical Medicine signed a Memorandum of Understanding to promote and further academic […]

Enrollment begins for Sanofi and GSK’s Phase 3 efficacy trial of COVID-19 vaccine candidate in Nepal, led by IVI

International Vaccine Institute (IVI) will lead the clinical trial in Nepal to assess the safety, efficacy and immunogenicity of an adjuvanted recombinant-protein COVID-19 vaccine candidate Phase 3 international clinical trial includes volunteers from several countries, including sites in the US, Asia, Africa and Latin America […]

IVI’s 20th International Vaccinology Course brings virtual training to vaccine professionals and students across 155 countries

September 10, 2021, SEOUL, Korea — The International Vaccine Institute’s (IVI) 20th International Vaccinology Course (IVC) concluded today, bringing together 7,350 registered trainees and 27 faculty members for 5 days of online lectures on a range of topics related to the science of vaccines with […]

IVI 20th International Vaccinology Course kicks off September 6, 2021

Learn more and register for the free 5-day virtual course (6-10 September 2021) on a range of topics related to vaccinology here September 6, 2021 SEOUL, Korea — The International Vaccine Institute’s (IVI) 20th annual International Vaccinology Course (IVC), a 5-day free, online course begins […]

President Duque of Colombia visits the International Vaccine Institute

The President of Colombia delivers letter of intent for Colombia to join IVI IVI and Colombia’s Ministry of Health and Social Protection sign memorandum of understanding August 25, 2021 – SEOUL, Republic of Korea – The President of the Republic of Colombia, His Excellency Iván […]

IVI and BBIL launch global Chikungunya vaccine Phase II/III trial in Costa Rica

IVI is leading the Global Chikungunya vaccine Clinical Development Program (GCCDP) consortium in partnership with Bharat Biotech International Ltd. and with support from the Coalition for Epidemic Preparedness Innovations (CEPI) and Ind-CEPI.   August 24, 2021 – SEOUL, Republic of Korea – The International Vaccine […]

IVI appoints ballerina Sae Eun Park to IVI Goodwill Ambassador

August 18, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) named Sae Eun Park, an award-winning ballet dancer from Korea, an IVI Goodwill Ambassador during a virtual ceremony in Seoul today.   Ms. Park was named danseuse étoile, the highest-level dancer, […]

IVI partners with SK bioscience to conduct late-stage global clinical trials of SK bioscience’s COVID-19 vaccine

IVI to conduct Phase 3 clinical trials of SK bioscience’s recombinant protein vaccine candidate (GBP510) in Europe and Southeast Asia   Additionally, IVI forms partnership with SK and KNIH to jointly conduct antibody testing for the global trials to accelerate development of “Wave 2” vaccines […]

THECA consortium begins Vi-TT typhoid conjugate vaccine phase IV effectiveness study in Ghana

July 26, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) announced today the start of a cluster-randomized, controlled Phase IV trial to assess the effectiveness of Typbar® typhoid conjugate vaccine (TCV) in preventing typhoid infection in children in Asante Akim, Ghana […]

CEPI and IVI collaborate on clinical research to expand access to COVID-19 vaccines in Africa

July 20, 2021; Oslo, Norway and Seoul, Republic of Korea: The Coalition for Epidemic Preparedness Innovations (CEPI) and the International Vaccine Institute (IVI) today announced a new programme of clinical research which aims to expand access to COVID-19 vaccines in Africa. CEPI will provide funding […]

IVI welcomes Bangladesh as state party with ratification ceremony

  July 15, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) hosted a ceremony at headquarters today honoring the People’s Republic of Bangladesh’s ratification of the IVI Establishment Agreement. Over 20 years of vaccine research and capacity-building initiatives with partners in Bangladesh […]

IVI and KNUST establish collaborating center to conduct vaccine research and development for global health

July 5, 2021 – SEOUL, Republic of Korea and KUMASI, Ghana – The International Vaccine Institute (IVI) and the Kwame Nkrumah University of Science and Technology (KNUST) opened the KNUST-IVI Collaborating Center today with a ceremony at KNUST/Agogo Presbyterian Hospital.   The KNUST-IVI Collaborating Center […]

IVI organizes ROK-Australia-ASEAN Vaccine Forum to promote inclusive and sustainable recovery from the COVID-19 pandemic

The ROK-Australia-ASEAN Vaccine Forum took place in hybrid live/virtual format with transmission from Seoul on June 29, 2021   June 29, 2021 – SEOUL, Republic of Korea – The International Vaccine Institute (IVI) organized, and the Republic of Korea’s Ministry of Foreign Affairs (MOFA) and […]

IVI to develop an adaptive Phase 1b/2a schistosomiasis vaccine clinical trial

May 31, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded a grant to IVI to develop an adaptive trial design protocol for a Phase 1b/2a clinical trial of a schistosomiasis vaccine.   […]

International Vaccine Institute and FII Institute sign MOU to cooperate on scientific research and publication

The agreement is an effort to further scientific research in infectious diseases and make knowledge more accessible through advocacy and joint publications.   May 19, 2021 – SEOUL, South Korea, RIYADH, Saudi Arabia – The International Vaccine Institute (IVI) and the Future Investment Initiative Institute […]

International Vaccine Institute and Institut Pasteur Korea Sign MOU for Research and Development of Infectious Disease Therapeutics and Vaccines

April 1, 2021, GYEONGDO-DO and SEOUL, Korea – The International Vaccine Institute (IVI) and the Institut Pasteur Korea (IPK) signed a memorandum of understanding (MOU) for mutual collaboration in the research and development of therapeutics and vaccines for infectious diseases.   The MOU signing ceremony, […]

IVI signs Memorandum of Understanding with the Nepal Health Research Council

  March 12, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) and the Nepal Health Research Council (NHRC) signed a Memorandum of Understanding (MoU) today during a virtual ceremony, laying the foundation for the two organizations to build research and development capacity […]

IVI welcomes Bangladesh’s accession to IVI

March 9, 2021 – SEOUL, South Korea – The International Vaccine Institute (IVI) welcomes the Cabinet of Bangladesh’s decision to ratify the IVI Establishment Agreement on February 22, 2021, completing the full accession process to IVI and becoming its 19th State Party.     Bangladesh is a founding signatory to IVI’s […]

George Bickerstaff re-elected Chairperson of the International Vaccine Institute’s Board of Trustees

February 22, 2021, SEOUL, Korea – The International Vaccine Institute (IVI) announced today that its Board of Trustees (BOT) re-elected Mr. George Bickerstaff as Chairperson of the BOT. His second three-year term will begin this May.   Mr. Bickerstaff has served on the IVI Board […]

GI-Cell, IVI sign MOU to develop next-generation COVID-19 vaccine

To cooperate in clinical development of COVID-19 vaccine candidate GI-Cell aims to prioritize supplying to Korea and developing countries by developing a vaccine that accommodates mass supply, viral mutation response, safety, convenience of patients January 26, 2021, SEOUL, Korea – GI-Cell, an affiliate of GI-Innovation, […]

Cellid, IVI exchange ‘COVID-19 Vaccine Research Service Contract’

IVI to analyze samples from Phase 1/2a trials of Cellid’s COVID-19 vaccine to evaluate immunogenicity   January 5, 2021, SEOUL, Korea –  Cellid and the International Vaccine Institute (IVI) have exchanged a collaborative research agreement to analyze the immunogenicity of the COVID-19 vaccine “AdCLD-CoV19”.   […]

IVI-SK’s new typhoid conjugate vaccine meets primary endpoints in phase III study in Nepal

Primary analysis also confirms safety of Vi-DT   December 17, 2020 – SEOUL, South Korea – Vi-DT typhoid conjugate vaccine, developed jointly by the International Vaccine Institute (IVI) and SK bioscience, has met the primary endpoints in a phase III study in Nepal. The primary […]

EuBiologics partners up with IVI in COVID-19 vaccine development

December 3, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) and EuBiologics exchanged an MOU to cooperate in clinical development of the COVID-19 vaccine the company is currently developing. The signing ceremony at IVI headquarters on December 2 was attended by Dr. Jerome […]

How to take action on AMR during the COVID-19 pandemic, a webinar co-hosted by IVI, ICARS, and the Embassy of Denmark in Korea

Free webinar, Evidence to Action: Advancing the Antimicrobial Resistance Agenda during a Pandemic, will be held on Thursday, December 3, 2020 at 9:00 Central European Time (17:00 Korean Standard Time). Registration available at ivi.int/evidence-to-action/    December 1, 2020, SEOUL, Korea — The International Vaccine Institute […]

IVI celebrates GivingTuesday with local community heroes and launches new donation initiative

December 1, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) visited the Seoul Gwanak Police Station today to recognize the Foreign Affairs section for their ongoing support for IVI’s activities and to deliver protective face masks and medical supplies for staff and volunteers. […]

IVI, ROK’s GDEF join forces to provide OCV vaccination to 540,000 people at risk of cholera in Nepal and Mozambique

GDEF’s US$8.05 million grant to support ECHO projects to prevent and control cholera and contribute to ‘Ending Cholera—A Global Roadmap to 2030’   The International Vaccine Institute (IVI) and the Republic of Korea’s Global Disease Eradication Fund (GDEF) have agreed to conduct joint projects to […]

IVI and the Ministry of Foreign Affairs and Human Mobility of Ecuador exchange MOU to pursue global health research & development

November 24, 2020, SEOUL, Republic of Korea — The International Vaccine Institute (IVI) and the Ministry of Foreign Affairs and Human Mobility of Ecuador exchanged a memorandum of understanding (MOU) today at IVI headquarters in Seoul, Republic of Korea to explore areas of collaboration in […]

LG Electronics, IVI join forces to conduct a ‘cholera vaccination and prevention project’ in Ethiopia

Project to provide vaccination for 40,000 residents in areas at risk of cholera and establish disease monitoring system with the Ethiopian Ministry of Health through the Armauer Hansen Research Institute (AHRI) To contribute to health authorities in policymaking for disease prevention by investigating waterborne diseases […]

IVI, Vaccine Innovative Technology ALliance Korea (VITAL-Korea) to partner up for innovative vaccine research and development

Aim to accelerate R&D and globalization of Korean vaccines to increase contributions to global health     The International Vaccine Institute (IVI) and the Vaccine Innovative Technology ALliance Korea (VITAL-Korea) agreed to join forces to promote vaccine research and development for global health.   IVI […]

International Vaccine Institute honored with Minister of Health and Welfare Award for achievements in biosafety

October 28, 2020, SEOUL, Korea —  The International Vaccine Institute (IVI) received an award by the Minister of Health and Welfare of the Republic of Korea for achievements in biosafety management.   IVI was honored with the Minister of Health and Welfare Award for achievements in […]

The International Vaccine Institute Supports a Global Campaign to Reduce the Spread of Covid-19

The International Vaccine Institute (IVI) is partnering with the World Sanity Foundation (WSF) in a campaign to encourage the use of face masks in an effort to reduce the spread of COVID-19 cases until a safe and effective vaccine becomes widely available.   The first […]

IVI and global health partners encourage vaccine diplomacy

October 13, 2020, SEOUL, Korea — The International Vaccine Institute (IVI) hosted a virtual State Forum today to advocate for multilateral cooperation through vaccine diplomacy. During a coronavirus pandemic with the continuous threat of more neglected infectious diseases spreading around the world, the forum convened […]

Typhoid: Study confirms Vi-DT conjugate vaccine is safe and immunogenic in children 6-23 months of age

September 17, 2020 – SEOUL, South Korea – A new study conducted by IVI in collaboration with SK bioscience shows that single-dose and two-dose regimens of Vi-DT typhoid conjugate vaccine (TCV) are safe and immunogenic in children 6-23 months of age, a group with high […]

IVI to ready clinical trial sites for COVID-19 vaccine efficacy trials in 4 countries

September 9, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI) announced today that the Bill & Melinda Gates Foundation awarded close to 1.5 million USD to IVI to support clinical trial site preparedness in four African and Asian countries to potentially support future COVID-19 Phase III efficacy vaccine trials.     Following successful completion of early-stage clinical trials of COVID-19 vaccine candidates, it will be […]

IVI welcomes Finland as 36th member state with flag-raising ceremony

  August 10, 2020 – SEOUL, South Korea – The flag of Finland was raised at the International Vaccine Institute (IVI) Headquarters today during a ceremony welcoming the country’s accession to IVI. Finland joined the Seoul-based international organization dedicated to vaccines for global health in […]

IVI welcomes the First Lady of South Korea to a solidarity event for global health and vaccine equity

IVI hosted the “Shared Future, Global Solidarity: Vaccines Save Lives” event at its headquarters on July 8, 2020, attended by the First Lady, Minister of Health, Vice Minister of Foreign Affairs, Director of National Institute of Health of Korea, and foreign ambassadors to South Korea […]

LINE and International Vaccine Institute Release BT21 Donation Stickers to Promote Global Vaccination and Vaccine Development

LINE FRIENDS’ BT21 characters featured in IVI sticker set to raise funds for child immunization initiatives and COVID-19 vaccine development   SEONGNAM, South Korea – June 30, 2020 – LINE Corporation today released a set of animated stickers together with the International Vaccine Institute (IVI) […]

IVI welcomes H.E. Einar H. Jensen, Ambassador of Denmark to South Korea, to discuss COVID-19 and AMR research

  June 16, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) welcomed His Excellency Einar H. Jensen, Ambassador of Denmark to South Korea, to IVI’s headquarters today to discuss developments in COVID-19 research as well as the institute’s ongoing studies on antimicrobial resistance […]

IVI partners with Seoul National University Hospital to start Phase 1/2 clinical trial of INOVIO’s COVID-19 DNA (INO-4800) vaccine in South Korea

First COVID-19 vaccine clinical study approved in South Korea funded by CEPI through INOVIO, and supported by KCDC/KNIH 2-stage trial to test INOVIO’s COVID-19 vaccine (INO-4800) using well-established DNA platform technology in adults     June 4, 2020, SEOUL, Korea and PLYMOUTH MEETING, PA, USA […]

CEPI awards up to US$14.1million to consortium of IVI and Bharat Biotech to advance development of Chikungunya vaccine in collaboration with Ind-CEPI

  June 3 2020, Oslo, Norway; Seoul, South Korea; Telangana, India—CEPI, the Coalition for Epidemic Preparedness Innovations, in collaboration with Ind-CEPI, has announced a new partnering agreement with a consortium comprising Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to advance the development of […]

IVI standardizes on Veeva Vault QualityDocs to Improve Operational Efficiency

SEOUL, KOREA — March 10, 2020 — Veeva Systems (NYSE:VEEV) today announced that the International Vaccine Institute (IVI), a not-for-profit International Organization established in 1997 as an initiative by the United Nations Development Programme (UNDP), has implemented Veeva Vault QualityDocs to improve control and real […]

IVI presents COVID-19 vaccine and epidemiology research to H.E. Philippe Lefort, Ambassador of France to Korea

May 22, 2020, SEOUL, South Korea – The International Vaccine Institute (IVI) invited French Ambassador to Korea, Philippe Lefort, to IVI’s headquarters in Seoul, Korea today to share ongoing research and development on COVID-19.   His Excellency Philippe Lefort, French Ambassador to Korea (left), and […]

IVI to strengthen COVID-19 surveillance in sub-Saharan Africa with support from Sweden

IVI will leverage its network of infectious disease surveillance sites to conduct epidemiological studies of COVID-19 in Madagascar and Burkina Faso Sida’s contribution will significantly build in-country capacity to proactively respond to the pandemic     May 21, 2020 – SEOUL, South Korea – The […]

INOVIO and GeneOne Life Science Report Positive Phase 1/2a Clinical Data With DNA Vaccine INO-4700 for MERS Coronavirus at the American Society of Gene & Cell Therapy (ASGCT) Conference

INO-4700 (GLS-5300) DNA vaccine demonstrates 100% binding and 92% neutralizing antibody responses against MERS-CoV INO-4800 DNA vaccine for COVID-19 currently in Phase 1 trial utilizes identical strategy targeting Spike protein and CELLECTRA intradermal delivery   PLYMOUTH MEETING, Pa. and SEOUL, KOREA – April 28, 2020 […]

LINE and International Vaccine Institute Team Up to Promote the Importance of Vaccination

LINE to offer an Official Account to IVI to promote the importance of vaccines and vaccination, as well as feature educational contents starring IVI Goodwill Ambassador Henry Lau LINE FRIENDS’ BT21 character IVI sticker set to be launched in the first half of the year […]

IVI, INOVIO, and KNIH to partner with CEPI in a Phase I/II clinical trial of INOVIO’s COVID-19 DNA vaccine in South Korea

  The Coalition for Epidemic Preparedness Innovations (CEPI) grants funding $6.9 million to INOVIO and IVI to conduct clinical testing in Korea for INOVIO’s COVID-19 vaccine candidate based on their well-established DNA platform technology Korea National Institute of Health (KNIH) to support IVI’s testing efforts […]

International Vaccine Institute and Technical University of Denmark to strengthen external quality assurance in the face of rising antimicrobial resistance in Asia

The Asia Pacific region is vulnerable to the emergence and spread of AMR but there is little high-quality data available on the extent of its impact Quality-assured data is essential for building tailored strategies for preventing the spread of drug-resistant infections IVI is part of […]

IVI and Sweden renew partnership to accelerate vaccines for global public health

    January 13, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI), a Seoul, Korea-based international organization, announced today that the Swedish International Development Cooperation Agency (Sida) will continue to support IVI’s mission to accelerate vaccine research and development for global health […]

IVI to lead critical standard reagents availability for oral cholera vaccine manufacturing to ensure their uniform efficacy and help meet global demand

  January 9, 2020 – SEOUL, South Korea – The International Vaccine Institute (IVI) received a $1.4 million grant from the Bill & Melinda Gates Foundation to ensure critical standards and reagents are available to low-cost oral cholera vaccine (OCV) manufacturers in the global health […]

IVI appoints three new members to its Board of Trustees

December 18, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI), a Seoul, Korea-based international organization dedicated to accelerating vaccines for global health, announced today that Professor Gordon Dougan, Dr. Melanie Saville, and Dr. Jean-Marie Okwo-Bele will join its Board of Trustees (BOT) […]

IVI to Accelerate Efforts in iNTS Vaccine Development

An award from the Wellcome Trust’s Affordable Innovations for Global Health Flagship will support IVI’s development and selection of potential vaccine candidates There is currently no vaccine available to protect against invasive non-typhoidal salmonella (iNTS)   November 13, 2019 – SEOUL, South Korea – The […]

IVI acquires GCLP certification from Korean Ministry of Food and Drug Safety

Institute expected to increase contributions to vaccine development activities worldwide   November 1, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI), an international organization for vaccine development and delivery headquartered in Seoul, has been granted Good Clinical Laboratory Practice (GCLP) certification by […]

IVI Awarded $4.5 Million Grant to Increase Accessibility of Oral Cholera Vaccine

October 28, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI) has received a $4.5 million grant from the Bill & Melinda Gates Foundation to simplify the current oral cholera vaccine (OCV) and further increase its accessibility. To date, the Gates Foundation has […]

IVI Discusses Expanding Support for Global Collaboration on Vaccine R&D and Delivery with Top Foreign Diplomats in Seoul

IVI State Forum 2019 was attended by 8th UN Secretary-General Ban Ki-moon, as well as 30 distinguished guests, including 17 ambassadors and top diplomats in Seoul, and senior Korean government officials.   The IVI State Forum 2019 was attended by ambassadors and senior diplomats from […]

IVI-led Consortium Awarded Fleming Fund Regional Grant to Improve Data Sharing in Fight against Antimicrobial Resistance

September 24, 2019, SEOUL, Korea – The Chief Medical Officer for England, Dame Sally Davies, announced today during the 74th UN General Assembly that a consortium led by the International Vaccine Institute (IVI) has been awarded a £2.7m Fleming Fund Regional Grant to improve data […]

IVI to help developing countries tackle the spread of infectious diseases by building capacity through vaccinology training in Seoul

19th IVI International Vaccinology Course brings together 175 trainees and faculty members from 49 countries The annual course has trained over 1,544 healthcare professionals in vaccine development, evaluation, production and policy to help increase developing nations’ capacity in vaccine research and immunization.     September […]

IVI acquires supplemental funding for Severe Typhoid in Africa Program (SETA Plus)

  August 28, 2019 – SEOUL, South Korea – The International Vaccine Institute (IVI) has received additional funds of $4.33 million from the Bill & Melinda Gates Foundation to expand Severe Typhoid in Africa (SETA) Program activities in close alignment with the “Effect of a […]

IVI Director General Dr. Jerome Kim to join the Human Vaccines Project’s Efforts as One of Four Distinguished Global Leaders to Decode the Human Immune System

August 16, 2019 – SEOUL, South Korea – Dr. Jerome Kim, Director General of the International Vaccine Institute (IVI), joins the Human Vaccines Project as one of four distinguished global leaders to help push forward its effort to solve one the greatest public health challenges […]

Prof. Young Chul Sung, biotech leader, personally donates US$8.4 million to IVI

Fund to support IVI’s projects to vaccinate children in developing countries throughout Asia-Pacific and Africa, to develop vaccines against emerging viruses   Prof. Park Sang-chul, President of the Korea Support Committee for IVI, Prof. Sung Young-chul with his donation pledge and IVI Director General Dr. […]

New push to develop world’s first vaccine against the deadly Strep A bacteria killing hundreds of thousand

Streptococcus pyogenes bacteria, which causes scarlet fever and other infections   30 May 2019, SEOUL, South Korea – The International Vaccine Institute (IVI) and Australia’s Murdoch Children’s Research Institute (MCRI) will coordinate a global push to free the world of Group A Streptococcus (Strep A), […]

IVI-led CAPTURA consortium wins Fleming Fund award for work on antimicrobial resistance (AMR) data across Asia

SEOUL, South Korea — An international consortium, led by the International Vaccine Institute (IVI), has received funding from the UK’s Fleming Fund Regional Grants to conduct the Capturing Data on Antimicrobial Resistance (AMR) Patterns and Trends in Use in Regions of Asia (CAPTURA) project. The […]

IVI receives $15.7 million grant to conduct phase III trials of new Vi-DT typhoid conjugate vaccine manufactured by SK bioscience of Korea

– Grant from the Bill & Melinda Gates Foundation will support additional supply of novel TCV at affordable cost for public sector markets   SEOUL, Korea –The International Vaccine Institute (IVI) announces receipt of a $15.7 million-dollar grant from the Bill & Melinda Gates Foundation […]

‘IVI Forum for Enhancement of Cooperation’ hosted jointly by the Korean Parliamentary Forum for Global Health, and KCDC under MOHW

– Event organized by IVI to discuss ways of cooperation to help increase Korea’s vaccine self-sufficiency, and accelerate globalization of the Korean vaccine industry Key participants pose for a commemorative photo at the ‘IVI Forum for Enhancement of Cooperation’ at the National Assembly of the […]

Vaccine study confirms sensitivity of cholera test

Recently, the sensitivity of fecal microbiological cultures for detecting cholera has come under question. Researchers reporting in PLOS Neglected Tropical Diseases investigated this claim using a ‘vaccine probe’ analysis of a completed cholera vaccine cluster randomized trial to support the sensitivity of conventional microbiological culture […]

Korean Pediatric Association, IVI, KSC exchange MOU

KPA, as group of experts in pediatric infectious diseases, to collaborate in academic research and projects on infectious disease prevention To support vaccination of children in developing countries through the ‘One for Three’ campaign, in partnership with IVI     The International Vaccine Institute (IVI), […]

IVI receives $3.2 million grant to support TCV effectiveness studies in West Africa

  SEOUL, Korea — The International Vaccine Institute (IVI) has been awarded a $3,238,974 grant from the Bill & Melinda Gates Foundation to provide technical assistance support for studies to measure the effectiveness of typhoid conjugate vaccine (TCV) in West Africa. This grant comes after […]

CEPI partners with IVI to accelerate development of vaccines against emerging global health threats

– Bilateral ‘Master Implementing Partner Services Agreement’ expected to enable IVI to provide technical capabilities to CEPI   Oslo, Norway; Seoul, Republic of Korea 11 February 2019—The Coalition for Epidemic Preparedness Innovations (CEPI) and the Republic of Korea-based International Vaccine Institute (IVI), an international organisation […]

Henry Lau joins IVI as Goodwill Ambassador

– Singer-songwriter, Henry to team up with the International Vaccine Institute (IVI), founded by the United Nations Development Programme to develop and deliver new vaccines for global health – IVI Director General Dr. Jerome Kim: “IVI is privileged to have Henry on board, and grateful […]

Nature Communications study addresses MDR typhoid

New study in Nature Communications reveals high burden of multi-drug resistant (MDR) typhoid fever in sub-Saharan Africa associated with two predominant genotypes – IVI epidemiologist Se Eun Park and collaborating scientists report data from Typhoid Fever Surveillance in Africa (TSAP) program and other sources   […]

THSTI, IVI held joint symposium on Nov. 22

First cooperative program between International Vaccine Institute and Translational Health Science and Technology Institute expected to help accelerate cooperation between India and IVI IVI and the Translational Health Science and Technology Institute (THSTI) of India held a joint symposium at IVI headquarters on November 22. […]

‘The Euvichol story’ published in Vaccine

“The Euvichol Story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships” spearheaded by the International Vaccine Institute (IVI), has been published in Vaccine by Elsevier. The Euvichol Story published on October 9, 2018 in the […]

IVI accelerates development of MERS vaccine

– Institute jointly conducts phase 1/2a clinical trial of GeneOne Life Science’s GLS-5300 DNA MERS vaccine – IVI in search of additional promising candidate vaccines among developers worldwide, with support from Samsung Life Public Welfare Foundation   The International Vaccine Institute (IVI) said on September […]

IVI’s 18th Vaccinology Course gathers 120 international participants from 19 countries in Seoul September 3-7

Annual Course to update on the recent development in vaccinology, including basics of immunology, epidemiology, vaccine design and development Featured experts include: Stanley Plotkin (University of Pennsylvania), Dr. Barney Graham (US NIH), Dr. Randy Schoepp (USAMRID), Dr. Andy Pollard (University of Oxford), and Dr. Eric […]

KOICA, IVI team up with Mozambican MoH and INS, partners to vaccinate 190,000 people against cholera

– Joint initiative aims to prevent and control cholera, and secure sustainable cholera and diarrheal disease surveillance  – WASH campaign to promote access to clean water and behavioral change for appropriate sanitation and hygiene practice – “KOICA is joining the program to contribute to ‘Ending […]

IVI acquires $5 million grant to support process development, scale up of typhoid conjugate vaccine with SK Bioscience

– Grant from the Bill & Melinda Gates Foundation to allow SK Bioscience Co. Ltd, IVI to accelerate late-stage development of new vaccine necessary to achieve WHO prequalification The International Vaccine Institute (IVI), an international nonprofit organization devoted to providing vaccines critical to global public […]

×

Korean Ministry of Health and Welfare, International Vaccine Institute (IVI) sign agreement on vaccine development and delivery

Author
ivi
Date
2017-04-04 04:56
Views
12901
- Agreement to collaborate on vaccine R&D projects, capacity-building, and information-exchange programs between IVI, universities, research institutes and industry

- IVI Director General Jerome Kim thanks Korea for its support of global health R&D and vows to increase IVI’s cooperation with Korea

Dr. Chung Chin-youb (left), Minister of Health & Welfare, and Dr. Jerome Kim, Director General of the International Vaccine Institute after exchanging an MOU on bilateral cooperation at IVI headquarters in Seoul on April 3.

April 3,2017, SEOUL, KOREA - The Ministry of Health & Welfare of the Republic of Korea (MOH) and the International Vaccine Institute (IVI) signed a memorandum of understanding (MOU) on a collaboration to advance global public health, and to develop and deliver vaccines and related technologies for developing countries. Dr. Chung Chin-youb, Minister of Health & Welfare, visited the IVI headquarters at Seoul National University Research Park on April 3rd and exchanged the MOU with IVI Director General Dr. Jerome Kim, and discussed plans on mutual cooperation between Korea and the institute.

Established in 1997, IVI was the first international organization headquartered in Korea.  As IVI’s host country, Korea provides funding through its Official Development Assistance (ODA) to the institute for its vaccine research and operations. Up until recently, the institute was under the Ministry of Education. This MOU is a revision of the MOU signed in 2013 between the Ministry of Education and IVI, and includes newly added areas of support and expanded cooperation between IVI and MOH such as joint vaccine R&D projects and capacity-building initiatives.

Under the purview of MOH, IVI will continue to receive funding from the Korean government to support its operations as per the original host country agreement signed between IVI and Korea. The Ministry will also continue to support IVI's vaccine research and development activities to help the institute fulfill its mission of making safe, effective and affordable vaccines available for global health.

Finally IVI and the Ministry agreed to actively support exchange and cooperation programs in Korea by collaborating more with Korean universities, research institutes and the life sciences industry.  Notably, IVI and the Korean Centers for Disease Control will partner to develop vaccines against norovirus and hepatitis A.



IVI has a proven track record of partnering with Korean companies on vaccine development and commercialization for the global public health market. It transferred the oral cholera vaccine technology to the bio-venture company EuBiologics, and their oral cholera vaccine (Euvichol) is stockpiled by the World Health Organization (WHO) and used by United Nations agencies such as UNICEF.  IVI also developed a new typhoid conjugate vaccine, and transferred the technology to SK Chemicals.  The two organizations are currently conducting clinical trials in the Philippines with the intent of having the vaccine approved for global use by WHO.

"I would like to extend our profound gratitude to the Republic of Korea for its lasting commitment and generous support to IVI and to global health,” said IVI Director General Dr. Jerome Kim. “We look forward to being an essential international cooperation partner of Korea by working with Korean academia, industry and research institutes and helping them develop and deliver new and improved vaccines for the world.”

Dr. Chung Chin-youb (right), Minister of Health & Welfare, takes a guided tour to laboratories at the International Vaccine Institute on April 3rd after exchanging an MOU on bilateral cooperation with IVI Director General Dr. Jerome Kim

About IVI

The International Vaccine Institute (IVI) is the world’s only international organization devoted exclusively to developing and introducing new and improved vaccines to protect the world’s poorest people, especially children in developing countries. Established in 1997, IVI operates as an independent international organization under a treaty signed by 35 countries and the World Health Organization. The Institute conducts research in more than 20 countries of Asia, Africa and Latin America on vaccines against enteric and diarrheal infections, Japanese encephalitis, MERS-CoV, and dengue fever, and develops new and improved vaccines at its headquarters in Seoul, Republic of Korea. For more information, please visit http://www.ivi.int.